DATATRAK offsets $1.9M operating loss, rising backlog

Via a "rationalized business model and renewed focus," DATATRAK is on track with initiatives to "right-size, remain customer centric and increase product expansion," says chairman Laurence Birch. The company ended 2009 with a 31 percent revenue decrease and a $1.9 million operating loss. But a rising backlog now stands at $9.5 million. During the year, it launched the ONE unified e-clinical platform concept, which contrasts with the integrated architecture of many competitor products. The company also grew is CTO partner program, expanded its presence in Japan,  and welcomed back original eClinical product architect Chris Wilke, now chief technology officer. Financials release

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.